The most important lesson is that if both receptors are blocked, healthy individuals will develop glucose intolerance
Recommended Starting Dose of Retatrutide Phase 2 trial protocols typically initiated retatrutide at 2 mg once weekly via subcutaneous injection, allowing gradual physiological adaptation before dose escalation
Note that 9 mg and 12 mg are now the Phase-3-validated doses, while 1 mg, 4 mg, and 8 mg remain Phase 2 / research reference points
GCGR/GLP-1R agonist: OR: 0.32, 95%CI: 0.200.52, P = 3.93 10 6
When to talk to your provider Contact your provider if you experience no appetite suppression after 4 weeks of consistent use, if side effects worsen rather than improve over time, if you develop mouth sores or persistent oral irritation, or if your results plateau significantly after previously good progress
drugs.com 8Middleway Nutrition (June 2026)